Angelo Del Gaudio
Papers
1
Total Citations
49
H-Index
1
About
Angelo Del Gaudio is a leading voice in the evolving landscape of pancreatic oncology, where his work bridges the critical gap between emerging science and clinical practice. His research centers on precision medicine for pancreatic ductal adenocarcinoma, with a particular focus on overcoming the disease’s notorious diagnostic delays and therapeutic resistance. In his landmark 2023 review, “State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care,” Del Gaudio synthesized the latest advances in molecular profiling, targeted therapies, and early detection strategies—a contribution that has already garnered 49 citations and is shaping how clinicians and researchers approach this devastating malignancy. Beyond this highly cited work, his broader portfolio explores the integration of liquid biopsies and novel biomarker panels to enable earlier intervention, directly addressing the high mortality that plagues the field. Del Gaudio’s impact lies not only in his citation metrics but in his ability to translate complex molecular insights into actionable clinical roadmaps. For students and researchers entering pancreatic cancer research, his work offers a clear, forward-looking framework for understanding where the field stands—and where it must go next.
Research Focus
Key Achievements
Top Papers
- 1